Perimeter Medical Imaging AI announced that a previously announced reverse take-over has been completed and, as a result, Perimeter will be listed on the TSX-V. In addition, Perimeter closed its previously announced $10-million financing round.

Cyclica has announced the close of a CAD$23M Series B round of financing.

The Toronto Region Board of Trade’s has launched Recovery Activation Program (RAP), an immersive online workshop program to provide businesses with guidance, mentorship and practical advice about process modernization and end-to-end digital transformation.

Century Therapeutics has announced that it has acquired Empirica Therapeutics, allowing the company to develop its iPSC derived allogeneic cell therapies against glioblastoma (GBM).

Bausch Health Companies has announced that Health Canada has approved the use of DUOBRII™ lotion, a topical prescription medicine used to improve the signs and symptoms of plaque psoriasis in adult patients with moderate to severe plaque psoriasis.

Fusion Pharmaceuticals has announced that it expects to sell 8.35 million shares ranging from $14 to $16 in its initial public offering.

The Health Research Foundation (HRF) of Innovative Medicines Canada (IMC) have announced details of the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research.

MyndTec has partnered with Maness Veteran Medical to distribute its MyndMove™ Device to the US Department of Defense and The Department of Veterans Affairs.

Epineuron Technologies, Inc., announces the completion of a financing round to support production development and clinical validation for its neuroregenerative technology - designated a breakthrough device by the FDA.

Spiderwort Inc. has announced the closing of their $2.5 million USD Series Seed round financing.

VBI Vaccines Inc. has announced that it has entered into a debt financing facility for up to $50 million with K2 HealthVentures.

Flosonics Medical is one of the winners of the Vale COVID-19 challenge to help move solutions to market.

Lumira Ventures has launched the Double Bottom Line Challenge to provide funding to community organizations which are supporting groups that have been significantly affected by COVID-19.

The Velocity Fund Pitch Competition is open for applications. The Fund will invest $50,000 to $100,000 in each of the top four promising, early-stage companies.

Dr. Michael Rudnicki, Senior Scientist and Program Director, Ottawa Health Research Institute, has been named a Fellow of The Royal Society.

Microbix Biosystems has attained medical devices establishment licensing from Health Canada, allowing the immediate use of its quality assessment products by clinical laboratories across the country,

Spartan Bioscience has received approval from Health Canada for its rapid and portable COVID-19 test.

Microbix Biosystems Inc. and Oneworld Accuracy have announced a collaboration to provide a global external quality assessment (EQA) program to support clinically-effective COVID-19 testing.

Mobio Health has announced that it has teamed up with the New York University School of Medicine and the Zurich Psychiatry Hospital to deliver free digital stress-resilience training.

Self Care Catalysts has launched a collaboration with Roche through the Roche COVID-19 Data Science Coalition project. The initiative will use Self Care Catalysts’ Health Storylines as the offiicial COVID-19 app that will collect data from the community.